Circulating immune cells in cerebral small vessel disease: a systematic review

L Van der Taelen1,2, A M Briones3, T Unger2

  • 1Department of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.

Biogerontology
|May 5, 2025
PubMed

Insights

Circulating immune cells, particularly monocytes and ratios like NLR, MHR, and LMR, are linked to cerebral small vessel disease (cSVD) progression and features. These blood markers may offer new diagnostic and prognostic insights for cSVD.

Area of Science:

  • Neurology
  • Immunology
  • Radiology

Background:

  • Cerebral small vessel disease (cSVD) affects brain's small blood vessels and is common with aging.
  • Immune cell involvement in cSVD pathology is suggested but not well-defined.
  • Neuro-imaging features diagnose cSVD, but understanding underlying mechanisms is crucial.

Purpose of the Study:

  • To systematically review and synthesize evidence on circulating immune cells in cSVD.
  • To explore associations between peripheral immune cells and cSVD imaging features.
  • To identify potential blood-based biomarkers for cSVD diagnosis and prognosis.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Web of Science databases.
  • Inclusion of studies correlating peripheral immune cells with cSVD imaging markers.
  • Data extraction on study design, immune cell types, cSVD measures, and outcomes.

Main Results:

  • Pro-inflammatory monocytes linked to cSVD severity and progression.
  • Neutrophil-to-lymphocyte ratio (NLR) associated with white matter hyperintensities (WMH) and enlarged perivascular spaces.
  • Monocyte-to-HDL ratio (MHR) showed stronger associations with WMH, lacunes, and microbleeds than NLR.
  • Lymphocyte-to-monocyte ratio (LMR) correlated with slower WMH progression and lower cSVD prevalence.

Conclusions:

  • Circulating immune cells, especially monocytes and derived ratios (NLR, MHR, LMR), play a role in cSVD.
  • These ratios show potential as more reliable diagnostic and prognostic markers than individual cell counts.
  • Need for large-scale, prospective studies to confirm the role of these inflammatory markers in cSVD pathogenesis.